1-3 of 3
Hirokazu Kanegane
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Healthcare resources for inborn errors of immunity in the Asia-Pacific region

Motoi Yamashita, Yunfei An, Dharmagat Bhattarai, Vicky Wee Eng-Binas, Suravat Homvises, Intan Hakimah Ismail, Mahnaz Jamee, Dae Chul Jeong, Peter McNaughton, Dina Muktiarti, Satoshi Okada, Vu Van Quang, Amit Rawat, Monira Sarmin, Rajiva de Silva, Phub Tenzin, Lytheang Try, Youjia Zhong, Hsin-Hui Yu, Jane Chi Yan Wong, Yae-Jean Kim, Jaime S. Rosa Duque, Yu Lung Lau, Hirokazu Kanegane
Journal: Journal of Human Immunity
J Hum Immun (2025) 1 (2): e20250023.
https://doi.org/10.70962/jhi.20250023
Published: 13 May 2025
View articletitled, Healthcare resources for inborn errors of immunity in the Asia-Pacific region
Open the PDF for Healthcare resources for inborn errors of immunity in the Asia-Pacific region in another window
Journal Articles

Revisiting X-linked agammaglobulinemia

Hirokazu Kanegane, Kay Tanita, Madoka Nishimura, Dan Tomomasa, Kento Inoue, Toru Kanamori, Akira Nishimura, Hans D. Ochs
Journal: Journal of Human Immunity
J Hum Immun (2025) 1 (1): e20250020.
https://doi.org/10.70962/jhi.20250020
Published: 28 April 2025
View articletitled, Revisiting X-linked agammaglobulinemia
Open the PDF for Revisiting X-linked agammaglobulinemia in another window
Journal Articles

Primary and Safety Outcomes of a Phase 3 Open-Label, Single-Arm, 12-Week Study of Treatment with PI3Kδ Inhibitor Leniolisib in Pediatric Patients Aged 4–11 Years with Activated PI3Kδ Syndrome (APDS)

V. Rao, Manish J. Butte, Bénédicte Neven, Michaela Semeraro, Yael Gernez, Shanmuganathan Chandrakasan, Hirokazu Kanegane, Takahiro Yasumi, Kazushi Izawa, Alanvin Orpia, Ladan Foruraghi, Lauren Pauls, Lavenda Chirombo Kluczynski, Jason Bradt, Anurag Relan, Gulbu Uzel
Journal: Journal of Human Immunity
Series: CIS Meeting Abstracts 2025
J Hum Immun (2025) 1 (CIS2025): CIS2025abstract.6.
https://doi.org/10.70962/CIS2025abstract.6
Published: 25 April 2025
View articletitled, Primary and Safety Outcomes of a Phase 3 Open-Label, Single-Arm, 12-Week Study of Treatment with PI3Kδ Inhibitor Leniolisib in Pediatric Patients Aged 4–11 Years with Activated PI3Kδ Syndrome (APDS)